ATE235258T1 - Zubereitung zur diagnostik des stoffwechselsyndroms und der dieses syndrom zeigende krankheiten - Google Patents
Zubereitung zur diagnostik des stoffwechselsyndroms und der dieses syndrom zeigende krankheitenInfo
- Publication number
- ATE235258T1 ATE235258T1 AT96916423T AT96916423T ATE235258T1 AT E235258 T1 ATE235258 T1 AT E235258T1 AT 96916423 T AT96916423 T AT 96916423T AT 96916423 T AT96916423 T AT 96916423T AT E235258 T1 ATE235258 T1 AT E235258T1
- Authority
- AT
- Austria
- Prior art keywords
- syndrome
- metabolic syndrome
- diagnostics
- preparation
- cortisol
- Prior art date
Links
- 208000001145 Metabolic Syndrome Diseases 0.000 title abstract 3
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 208000011580 syndromic disease Diseases 0.000 title 1
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 abstract 6
- 229960000890 hydrocortisone Drugs 0.000 abstract 3
- 239000000556 agonist Substances 0.000 abstract 2
- 206010012601 diabetes mellitus Diseases 0.000 abstract 2
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 206010022489 Insulin Resistance Diseases 0.000 abstract 1
- 210000001015 abdomen Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000003925 fat Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Analytical Chemistry (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Steroid Compounds (AREA)
- Combined Controls Of Internal Combustion Engines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9501991A SE505391C2 (sv) | 1995-05-30 | 1995-05-30 | Användning av kortisol-agonister för framställning av ett system för diagnostisering av det metabola syndromet |
| PCT/SE1996/000708 WO1996038179A1 (en) | 1995-05-30 | 1996-05-30 | Preparation for diagnostic of the metabolic syndrome and diseases including the syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE235258T1 true ATE235258T1 (de) | 2003-04-15 |
Family
ID=20398470
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96916423T ATE235258T1 (de) | 1995-05-30 | 1996-05-30 | Zubereitung zur diagnostik des stoffwechselsyndroms und der dieses syndrom zeigende krankheiten |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6410339B1 (de) |
| EP (1) | EP0835138B1 (de) |
| JP (1) | JPH11505850A (de) |
| CN (1) | CN1078479C (de) |
| AT (1) | ATE235258T1 (de) |
| AU (1) | AU716671B2 (de) |
| BR (1) | BR9608683A (de) |
| CA (1) | CA2222215A1 (de) |
| DE (1) | DE69626982T2 (de) |
| DK (1) | DK0835138T3 (de) |
| ES (1) | ES2189872T3 (de) |
| NO (1) | NO319829B1 (de) |
| PT (1) | PT835138E (de) |
| RU (1) | RU2171471C2 (de) |
| SE (1) | SE505391C2 (de) |
| WO (1) | WO1996038179A1 (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7217505B2 (en) * | 1998-02-26 | 2007-05-15 | Cortendo Ab | Method for determining whether condition is symptom of metabolic syndrome |
| SE0001899D0 (sv) | 2000-05-22 | 2000-05-22 | Pharmacia & Upjohn Ab | New compounds |
| US20040220190A1 (en) * | 2002-07-29 | 2004-11-04 | Cincotta Anthony H. | Methods of treating metabolic syndrome using dopamine receptor agonists |
| US9655865B2 (en) | 2002-07-29 | 2017-05-23 | Veroscience, Llc | Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity, or prediabetes |
| US20080200453A1 (en) | 2002-07-29 | 2008-08-21 | Cincotta Anthony H | Methods of treating metabolic syndrome using dopamine receptor agonists |
| US20040081678A1 (en) * | 2002-08-09 | 2004-04-29 | Anthony Cincotta | Therapeutic process for the treatment of obesity and associated metabolic disorders |
| US8821915B2 (en) | 2002-08-09 | 2014-09-02 | Veroscience, Llc | Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders |
| US8137994B2 (en) * | 2004-03-25 | 2012-03-20 | Veroscience Llc | Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof |
| US20050215558A1 (en) * | 2004-03-25 | 2005-09-29 | Cincotta Anthony H | Methods of identifying responders to dopamine agonist therapy |
| US8137993B2 (en) * | 2004-03-25 | 2012-03-20 | Veroscience Llc | Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof |
| US20050232911A1 (en) * | 2004-04-19 | 2005-10-20 | Schreiber Brian D | Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid |
| DE102004034640A1 (de) | 2004-07-16 | 2006-02-16 | Institut für Molekular- und Systemmedizin | Verfahren zur systemischen Biokorrektur eines Organismus |
| RU2367950C2 (ru) * | 2005-03-28 | 2009-09-20 | Ижевский государственный технический университет | Способ прогнозирования развития метаболического синдрома при артериальной гипертонии у мужчин |
| US20090117660A1 (en) * | 2005-04-30 | 2009-05-07 | Oakville Hong Kong Co., Limited | Devices and methods for sample collection and analysis |
| RU2321354C2 (ru) * | 2006-04-21 | 2008-04-10 | Анатолий Николаевич Дмитриев | Способ диагностики стадий метаболического синдрома |
| JP2010505420A (ja) * | 2006-10-06 | 2010-02-25 | ネステク ソシエテ アノニム | 生理的健康の生物学的媒介物質を測定するための組成物及び多重アッセイ |
| RU2336807C1 (ru) * | 2007-05-30 | 2008-10-27 | Виктория Борисовна Мычка | Способ диагностики метаболического синдрома |
| US9352025B2 (en) | 2009-06-05 | 2016-05-31 | Veroscience Llc | Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders |
| RU2403868C1 (ru) * | 2009-07-07 | 2010-11-20 | Учреждение Российской академии медицинских наук Дальневосточный научный центр физиологии и патологии дыхания Сибирского отделения Российской академии медицинских наук (ДНЦ ФПД СО РАМН) | Способ оценки риска развития метаболического синдрома у больных хроническим холециститом |
| RU2444298C1 (ru) * | 2010-07-15 | 2012-03-10 | Учреждение Российской академии медицинских наук Научный центр клинической и экспериментальной медицины Сибирского отделения РАМН (НЦКЭМ СО РАМН) | Способ диагностики метаболического синдрома |
| CN105973881A (zh) * | 2016-04-27 | 2016-09-28 | 樊福好 | 一种检测机体活度的溶液及检测方法 |
-
1995
- 1995-05-30 SE SE9501991A patent/SE505391C2/sv not_active IP Right Cessation
-
1996
- 1996-05-30 ES ES96916423T patent/ES2189872T3/es not_active Expired - Lifetime
- 1996-05-30 CA CA002222215A patent/CA2222215A1/en not_active Abandoned
- 1996-05-30 JP JP8536000A patent/JPH11505850A/ja not_active Ceased
- 1996-05-30 CN CN96194229A patent/CN1078479C/zh not_active Expired - Fee Related
- 1996-05-30 AT AT96916423T patent/ATE235258T1/de not_active IP Right Cessation
- 1996-05-30 WO PCT/SE1996/000708 patent/WO1996038179A1/en not_active Ceased
- 1996-05-30 DK DK96916423T patent/DK0835138T3/da active
- 1996-05-30 PT PT96916423T patent/PT835138E/pt unknown
- 1996-05-30 EP EP96916423A patent/EP0835138B1/de not_active Expired - Lifetime
- 1996-05-30 US US08/952,638 patent/US6410339B1/en not_active Expired - Fee Related
- 1996-05-30 AU AU59173/96A patent/AU716671B2/en not_active Ceased
- 1996-05-30 DE DE69626982T patent/DE69626982T2/de not_active Expired - Fee Related
- 1996-05-30 RU RU97121292/14A patent/RU2171471C2/ru not_active IP Right Cessation
- 1996-05-30 BR BR9608683-1A patent/BR9608683A/pt not_active Application Discontinuation
-
1997
- 1997-11-28 NO NO19975492A patent/NO319829B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK0835138T3 (da) | 2003-07-21 |
| SE9501991D0 (sv) | 1995-05-30 |
| BR9608683A (pt) | 1999-12-07 |
| US6410339B1 (en) | 2002-06-25 |
| PT835138E (pt) | 2003-08-29 |
| WO1996038179A1 (en) | 1996-12-05 |
| RU2171471C2 (ru) | 2001-07-27 |
| EP0835138B1 (de) | 2003-03-26 |
| NO319829B1 (no) | 2005-09-19 |
| AU716671B2 (en) | 2000-03-02 |
| MX9709234A (es) | 1998-10-31 |
| ES2189872T3 (es) | 2003-07-16 |
| DE69626982D1 (de) | 2003-04-30 |
| CA2222215A1 (en) | 1996-12-05 |
| SE505391C2 (sv) | 1997-08-18 |
| EP0835138A1 (de) | 1998-04-15 |
| CN1185743A (zh) | 1998-06-24 |
| CN1078479C (zh) | 2002-01-30 |
| JPH11505850A (ja) | 1999-05-25 |
| NO975492D0 (no) | 1997-11-28 |
| AU5917396A (en) | 1996-12-18 |
| DE69626982T2 (de) | 2004-03-04 |
| SE9501991L (sv) | 1996-12-01 |
| NO975492L (no) | 1998-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69626982D1 (de) | Zubereitung zur diagnostik des stoffwechselsyndroms und der dieses syndrom zeigende krankheiten | |
| Ravitz et al. | Disturbances of Hypotha1amicPituitary-Adrena1 Axis functioning during ethanol withdrawal in six men | |
| De Pergola et al. | Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women | |
| Palesh et al. | Vagal regulation, cortisol, and sleep disruption in women with metastatic breast cancer | |
| Del Pinto et al. | Hypertension and periodontitis: a joint report by the Italian Society of Hypertension (SIIA) and the Italian Society of Periodontology and Implantology (SIdP) | |
| Hawkley et al. | Loneliness, dysphoria, stress and immunity: A role for cytokines | |
| Zahr et al. | Measurement of serum, liver, and brain cytokine induction, thiamine levels, and hepatopathology in rats exposed to a 4‐day alcohol binge protocol | |
| RU97121292A (ru) | Препарат для диагностики метаболического синдрома и заболеваний, включающих в себя данный синдром | |
| Saitou et al. | Local cyclical compression modulates macrophage function in situ and alleviates immobilization-induced muscle atrophy | |
| Miyazaki et al. | Effects of light-to-moderate intensity aerobic exercise on objectively measured sleep parameters among community-dwelling older people | |
| Amelia et al. | Relationship between family support with quality of life among type 2 diabetes mellitus patients at Amplas primary health care in Medan, Indonesia | |
| Alinezhad‐Namaghi et al. | Association of time‐restricted feeding, arterial age, and arterial stiffness in adults with metabolic syndrome | |
| Schmidt | Binge eating and binge eating disorder. | |
| Svane-Knudsen | Sudden “spontaneous” lesion of aural function | |
| Liu et al. | Asymmetry of habitual 24-hour intraocular pressure rhythm in glaucoma patients | |
| Levi | Methodological considerations in psychoendocrine research | |
| Beaudin et al. | Vascular responses to hypoxia are not impaired in obstructive sleep apnoea patients free of overt cardiovascular disease | |
| Del Seppia et al. | Evidence in hypertensive rats of hypotensive effect after mandibular extension | |
| DK1430322T3 (da) | Anvendelse af polariseret 129Xe til fremstilling af et medikament til anvendelse i en in vivo-NMR-fremgangsmåde | |
| Kirshen et al. | Comparison of urinary and serum amylase values following pancreatic stimulation in patients with and without pancreatic disease | |
| Wang et al. | Serum 25‐Hydroxyvitamin D Levels in Type 2 Diabetes Patients in North China: Seasonality and the Association between Vitamin D Status and Glycosylated Hemoglobin Levels | |
| Situmorang et al. | Emotion Distress and Self-Care Behavior in Type II Diabetes Mellitus Patients in Matsum, Medan, North Sumatera | |
| Podinic | Cognitive Performance in Adolescents with Type 2 Diabetes and Those Without: Pilot Data from a Case-Control Study | |
| Westaway et al. | Management of diabetes mellitus in outpatient facilities is achieving poor results | |
| Tu et al. | Sweat cortisol response to stress, macronutrient consumption and birth control |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0835138 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |